Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:49 PM
Ignite Modification Date:
2025-12-24 @ 6:49 PM
NCT ID:
NCT01615757
Eligibility Criteria:
Inclusion Criteria:
* Confirmation of Acute Myeloid Leukemia by morphologic, immunophenotypic analysis
* Suitable for HIDAC as consolidation
* AML with underlying MDS will be included
Exclusion Criteria:
* Previous AML chemotherapy \[Hydroxyurea - not an exclusion.\]
* CML-BC
* Concurrent active malignancy
* HIV infection, Uncontrolled Hepatitis B/C
* Patients being considered for upfront PBSCT (before completion of CONSOLIDATION)
* Serum Bilirubin \> 2
* APML
* Delayed recovery of blood counts /persistent active infection \> 45 days from start of induction
* Patients receiving reinduction with HIDAC
* Therapy related AML
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT01615757
Study Brief:
Protocol Section:
NCT01615757